First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors

NCT02160106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Stage Solid Tumors

Interventions

DRUG: TEW-7197

Sponsor

MedPacto, Inc.

Collaborators

[object Object]